Free Trial

Elevance Health (ELV) Stock Price, News & Analysis

Elevance Health logo
$281.75 -14.85 (-5.01%)
As of 02:17 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Elevance Health Stock (NYSE:ELV)

Key Stats

Today's Range
$280.55
$295.68
50-Day Range
$276.32
$412.49
52-Week Range
$274.40
$567.26
Volume
2.22 million shs
Average Volume
1.88 million shs
Market Capitalization
$63.44 billion
P/E Ratio
12.00
Dividend Yield
2.43%
Price Target
$432.69
Consensus Rating
Moderate Buy

Company Overview

Elevance Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
99th Percentile Overall Score

ELV MarketRank™: 

Elevance Health scored higher than 99% of companies evaluated by MarketBeat, and ranked 23rd out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Elevance Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 12 buy ratings, 6 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Elevance Health has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Elevance Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Elevance Health are expected to grow by 14.99% in the coming year, from $33.96 to $39.05 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elevance Health is 12.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.71.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elevance Health is 12.16, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.00.

  • Price to Earnings Growth Ratio

    Elevance Health has a PEG Ratio of 1.03. PEG Ratios around 1 indicate that a company is correctly valued.

  • Price to Book Value per Share Ratio

    Elevance Health has a P/B Ratio of 1.47. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.13% of the float of Elevance Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elevance Health has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elevance Health has recently increased by 1.60%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Elevance Health pays a meaningful dividend of 2.43%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Elevance Health has been increasing its dividend for 14 years.

  • Dividend Coverage

    The dividend payout ratio of Elevance Health is 29.11%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Elevance Health will have a dividend payout ratio of 17.52% next year. This indicates that Elevance Health will be able to sustain or increase its dividend.

  • Read more about Elevance Health's dividend.
  • Percentage of Shares Shorted

    1.13% of the float of Elevance Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Elevance Health has a short interest ratio ("days to cover") of 1.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elevance Health has recently increased by 1.60%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Elevance Health has a news sentiment score of 0.49. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.63 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 60 news articles for Elevance Health this week, compared to 31 articles on an average week.
  • Search Interest

    36 people have searched for ELV on MarketBeat in the last 30 days. This is an increase of 300% compared to the previous 30 days.
  • MarketBeat Follows

    17 people have added Elevance Health to their MarketBeat watchlist in the last 30 days. This is an increase of 183% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Elevance Health insiders have bought 25.14% more of their company's stock than they have sold. Specifically, they have bought $2,438,990.00 in company stock and sold $1,949,074.00 in company stock.

  • Percentage Held by Insiders

    Only 0.29% of the stock of Elevance Health is held by insiders.

  • Percentage Held by Institutions

    89.24% of the stock of Elevance Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Elevance Health's insider trading history.
Receive ELV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elevance Health and its competitors with MarketBeat's FREE daily newsletter.

ELV Stock News Headlines

September 4, 2024, Paraguay. In this photo illustration, the Centene Corporation logo is displayed on a smartphone screen — Stock Editorial Photography
Why Centene Stock Dropped 40% — And Whether It's a Buy Now (ELV)
Centene just crashed. But, price target updates signal the selloff is overdone, with 50% upside in play. However, the "Big Beautiful Bill" is another curveball.
Bitcoin Beats Gold — But This Coin Could Beat Them Both
Bitcoin just hit a record high—but it’s not the top crypto play right now. Crypto analyst Juan Villaverde, who called Bitcoin’s breakout to $100K nearly to the day, says a lesser-known coin could be even bigger. It’s faster, cheaper, and backed by Google, Visa, and top VCs with over $200 million already invested.
Elevance Health's (ELV) "Hold" Rating Reaffirmed at Argus
Elevance Health (NYSE:ELV) Sets New 52-Week Low on Analyst Downgrade
See More Headlines

ELV Stock Analysis - Frequently Asked Questions

Elevance Health's stock was trading at $368.90 at the beginning of the year. Since then, ELV shares have decreased by 22.6% and is now trading at $285.3580.

Elevance Health, Inc. (NYSE:ELV) posted its earnings results on Thursday, July, 17th. The company reported $8.84 earnings per share for the quarter, missing the consensus estimate of $9.30 by $0.46. The firm's revenue for the quarter was up 14.3% on a year-over-year basis.
Read the conference call transcript
.

Elevance Health subsidiaries include these companies: Beacon Health Options, Aspire Healthcare Corp, America’s 1st Choice, HealthSun Health Plans, Simply Healthcare Holdings, Amerigroup, 1-800 Contacts, and more.

Top institutional investors of Elevance Health include Focused Investors LLC (0.23%), Ninety One UK Ltd (0.17%), Assenagon Asset Management S.A. (0.17%) and Swedbank AB (0.16%). Insiders that own company stock include Gail Boudreaux, Gloria M Mccarthy, Felicia F Norwood, Charles Morgan Kendrick Jr, Robert L Dixon Jr, Ramiro G Peru and Ronald W Penczek.
View institutional ownership trends
.

Shares of ELV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Elevance Health investors own include NVIDIA (NVDA), Chevron (CVX), Meta Platforms (META), Advanced Micro Devices (AMD), Bristol Myers Squibb (BMY), Netflix (NFLX) and JPMorgan Chase & Co. (JPM).

Company Calendar

Record date for 6/25 Dividend
6/10/2025
Ex-Dividend for 6/25 Dividend
6/10/2025
Dividend Payable
6/25/2025
Last Earnings
7/17/2025
Today
7/24/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Managed Health Care
Current Symbol
NYSE:ELV
CIK
1156039
Employees
104,200
Year Founded
2004

Price Target and Rating

High Price Target
$529.00
Low Price Target
$310.00
Potential Upside/Downside
+45.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
18 Analysts

Profitability

EPS (Trailing Twelve Months)
$23.50
Trailing P/E Ratio
12.62
Forward P/E Ratio
8.73
P/E Growth
1.03
Net Income
$5.98 billion
Net Margins
2.83%
Pretax Margin
3.74%
Return on Equity
17.59%
Return on Assets
6.36%

Debt

Debt-to-Equity Ratio
0.64
Current Ratio
1.44
Quick Ratio
1.44

Sales & Book Value

Annual Sales
$177.01 billion
Price / Sales
0.38
Cash Flow
$41.24 per share
Price / Cash Flow
7.19
Book Value
$194.74 per share
Price / Book
1.52

Miscellaneous

Outstanding Shares
225,180,000
Free Float
224,525,000
Market Cap
$66.77 billion
Optionable
Optionable
Beta
0.60

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NYSE:ELV) was last updated on 7/24/2025 by MarketBeat.com Staff
From Our Partners